Pacira Pharmaceuticals Inc (PCRX.OQ)

PCRX.OQ on NASDAQ Stock Exchange Global Select Market

109.22USD
29 Aug 2014
Price Change (% chg)

$1.43 (+1.33%)
Prev Close
$107.79
Open
$107.72
Day's High
$107.72
Day's Low
$107.72
Volume
51,219
Avg. Vol
134,563
52-wk High
$109.94
52-wk Low
$36.05

PCRX.OQ

Chart for PCRX.OQ

About

Pacira Pharmaceuticals, Inc. is a United States-based pharmaceutical company. The Company develops non-opioid products for postsurgical pain control. Its products include EXPAREL (bupivacaine liposome injectable suspension) is a liposome injection of bupivacaine, an amide-type local anesthetic; DepoCyt(e) (cytarabine liposome... (more)

Overall

Beta: 1.41
Market Cap (Mil.): $3,885.66
Shares Outstanding (Mil.): 35.89
Dividend: --
Yield (%): --

Financials

  PCRX.OQ Industry Sector
P/E (TTM): -- 32.30 33.23
EPS (TTM): -1.28 -- --
ROI: -26.60 17.96 17.21
ROE: -41.77 18.60 18.01
Search Stocks

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, June 02,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Res

02 Jun 2014

DIARY-U.S. MEETINGS/WEEK AHEAD

THOMSON REUTERS, May 30,2014 - Corporate Meetings for US companies for Week ahead. S&P 500 Earnings - Weekly S&P 500 Earnings - Day Ahead Non S&P 500 - Weekly Non S&P 500 - Day Ahead ConferenceCall/Webcast - Weekly ConferenceCall/Webcast - Day S&P 500 Earnings - Monthly Meetings - Day Ahead Economic Indicators Dividends Daily earnings hits & misses Federal Rese

30 May 2014

Competitors

  Price Change
Kimberly Clark Corp (KMB.N) $108.00 -0.14
DURECT Corporation (DRRX.OQ) $1.58 --
Hospira, Inc. (HSP.N) $53.74 -0.48
Sanofi SA (SASY.PA) €83.26 -0.24
Bayer AG (BAYGn.DE) €95.41 -2.28
Bayer AG (BAYE.F) -- --
Abbott Laboratories (ABT.N) $42.24 -0.11
Roche Holding Ltd. (ROG.VX) CHF267.40 -0.30
Merck & Co., Inc. (MRK.N) $60.11 +0.11
Novartis AG (NOVN.VX) CHF85.25 +2.90

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks